drugset / Trial / NCT03121573

Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial

NCT03121573

Completed 30 enrolled Taichung Veterans General Hospital
SequentialOpen-labelHealth-services research

Summary

The aim of this study was to investigate the effects of duloxetine on improvement of brain cortical activity in patients suffering from major depressive disorder using near infrared spectroscopy.

Timeline

Start
2014-12-15
Primary completion
2016-09-26
Completion
2017-01-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 30 mg Oral
Subject Duloxetine Small molecule 60 mg Oral